CIDP
Showing 1 - 25 of 99
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Rozzano (Rituximab)
Active, not recruiting
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
-
Rozzano, Milano, ItalyIstituto Clinico Humanitas
May 17, 2023
Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP
Not yet recruiting
- CIDP
- IVIg
-
Nashville, TennesseeVanderbilt University
Nov 4, 2022
RWE-based Treatment Patterns and Outcomes in CIDP
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy
- +2 more
- No intervention. Retrospective observation only.
-
Salford, United KingdomNorthern Care Alliance NHS Foundation Trust
Jul 7, 2023
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Trial in Worldwide (Rozanolixizumab)
Completed
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
-
Scottsdale, Arizona
- +13 more
Mar 31, 2022
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Trial (Clinical examination, Functional scales, Walking test)
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Clinical examination
- +2 more
- (no location specified)
Aug 5, 2022
Disease Activity in Chronic Inflammatory Demyelinating
Recruiting
- CIDP
- Smartwatch (Withings Scanwatch)
-
Duesseldorf, Northrhine-Westphalia, GermanyMedical Faculty, Heinrich-Heine-University
Feb 1, 2023
Chronic Inflammatory Demyelinating Polyneuropathy Trial in Boca Raton, Austin (Batoclimab 680 milligrams (mg) subcutaneous (SC)
Recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy
- Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly
- +2 more
-
Boca Raton, Florida
- +1 more
Jan 31, 2023
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy Trial (Panzyga)
Not yet recruiting
- Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
- (no location specified)
Sep 2, 2022
CIDP, Immunoglobulin Deficiency, Chronic Inflammatory Demyelinating Polyneuropathy Trial in New Brunswick (Intravenous immune
Recruiting
- CIDP
- +2 more
- Intravenous immune globulin G
- Subcutaneous immune globulin G
-
New Brunswick, New JerseyRutgers, The State University of New Jersey Clinical Research Ce
Oct 13, 2022
Spinal Cord Injuries Trial in Sugar Land (HB-adMSCs)
No longer available
- Chronic Inflammatory Demyelinating Polyneuropathy
- HB-adMSCs
-
Sugar Land, TexasHope Biosciences Stem Cell Research Foundation
Sep 20, 2022
Chronic Inflammatory Demyelinating Polyneuropathy Trial in Atlanta (VitalStim 400, VitalStim400)
Recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy
- VitalStim 400
- VitalStim400
-
Atlanta, GeorgiaCenter for Advanced Pediatrics, Children's Healthcare of Atlanta
Sep 2, 2022
GAMMAGARD LIQUID in Chronic Inflammatory Demyelinating
Active, not recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
-
Durham, North CarolinaRTI Health Solutions
Jun 14, 2022
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Multifocal Motor Neuropathy (MMN) Trial in Japan (TAK-771)
Recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Multifocal Motor Neuropathy (MMN)
-
Nagoya, Aichi, Japan
- +16 more
Feb 2, 2023
Anti-aging Trial in Rio De Janeiro (Topical serum)
Completed
- Anti-aging
- Topical serum
-
Rio De Janeiro, BrazilCIDP Brasil
Sep 28, 2023
CIDP Trial in Ulm (Immunoadsorption, Immunoglobulins)
Not yet recruiting
- CIDP
- Immunoadsorption
- Immunoglobulins
-
Ulm, Baden-Württemberg, GermanyDepartment of Neurology, University of Ulm
Sep 28, 2021
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Trial in Canada, United States (IgPro10)
Recruiting
- Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- IgPro10
-
Phoenix, Arizona
- +8 more
Mar 24, 2022
UVA Protection Factors of SPF 50 and 50+ Face Sunscreens
Completed
- Ultraviolet-Induced Change in Normal Skin
-
Campinas, Brazil
- +5 more
Oct 4, 2023
CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTS
Completed
- Atopic Dermatitis
- Cosmetic study
-
Rio de Janeiro, BrazilCIDP
Mar 13, 2023
Polyneuropathy, Impairments and Physical Activity - The
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- +8 more
- Validity and reliability of outcome measures in polyneuropathy
- Healthy controls
- (no location specified)
Sep 15, 2023
Antibody-mediated Rejection, NMO Spectrum Disorder, TTP Trial in Iowa City
Recruiting
- Antibody-mediated Rejection
- +3 more
-
Iowa City, IowaDeGowin blood Center
Oct 31, 2022
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Trial (Rozanolixizumab)
Available
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- (no location specified)
Aug 19, 2021
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Trial in Japan (Rituximab (genetical recombination), Placebo)
Completed
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Rituximab (genetical recombination)
- Placebo
-
Nagoya, Aich, Japan
- +3 more
Aug 19, 2021
Guillain-Barre Syndrome Trial in Durham (Peripheral nerve ultrasound, Measurement of strength)
Enrolling by invitation
- Guillain-Barre Syndrome
- Peripheral nerve ultrasound
- Measurement of strength
-
Durham, North CarolinaDuke University Hospital
Sep 20, 2022
The Benefit ofDeep Cleansing Gel in Management of Mild to
Completed
- Acne
- Deep Cleansing Gel
-
Rio de Janeiro, BrazilCIDP
Oct 14, 2022
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial in Worldwide (SAR445088 (IV), SAR445088 (SC))
Recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- SAR445088 (IV)
- SAR445088 (SC)
-
Los Angeles, California
- +28 more
Aug 24, 2022